Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan-Reference-Cited by-同舟云学术

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan

Published:2020-06-25 Issue:8 Volume:63 Page:779-786
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Hamada Yukihiro¹,Ueda Takashi²^ORCID,Miyazaki Yoshitsugu³,Nakajima Kazuhiko²,Fukunaga Keiko⁴,Miyazaki Taiga⁵,Nakada‐Motokawa Nana⁵,Nagao Miki⁶,Kawamura Hideki⁷,Shigemi Akari⁷,Ebihara Fumiya¹,Kimura Toshimi¹,Ikegame Kazuhiro⁴,Uchino Motoi⁸,Ikeuchi Hiroki⁸,Takesue Yoshio²

Affiliation:

1. Department of Pharmacy Tokyo Women's Medical University Hospital Tokyo Japan

2. Department of Infection Control and Prevention Hyogo College of Medicine Nishinomiya Japan

3. Department of Chemotherapy and Mycoses National Institute of Infectious Diseases Tokyo Japan

4. Department of Hematology Hyogo College of Medicine Nishinomiya Japan

5. Department of Respiratory Medicine Nagasaki University Hospital Nagasaki Japan

6. Department of Infection Control and Prevention Kyoto University Hospital Kyoto Japan

7. Division of Medical and Environmental Safety Department of Infection Control and Prevention Kagoshima University Hospital Kagoshima Japan

8. Department of Surgery Hyogo College of Medicine Nishinomiya Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13129

Reference30 articles.

1. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

2. ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

3. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan

4. Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

5. Hallucinations during Voriconazole Therapy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients;Drug Design, Development and Therapy;2024-08

2. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis;Medical Mycology Journal;2024-07-31

3. Effectiveness and safety of the simulation-based first-dose design of voriconazole;Journal of Infection and Chemotherapy;2024-06

4. Astragalus Polysaccharide Enhances Voriconazole Metabolism under Inflammatory Conditions through the Gut Microbiota;Journal of Clinical and Translational Hepatology;2024-04-19

5. Development of a therapeutic drug‐monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study;British Journal of Clinical Pharmacology;2024-02-06